Lifecore Biomedical's Upcoming Key Industry Engagements
Engagements at Major Industry Conferences
Lifecore Biomedical, Inc. (NASDAQ: LFCR), a leading contract development and manufacturing organization, has exciting plans ahead as they participate in three significant industry events. Their commitment to advancing pharmaceutical development and manufacturing is highlighted through these engagements, showcasing their dedication to innovation and collaboration.
Annual Partnership Opportunities in Drug Development (PODD)
Conference Overview
The 15th Annual PODD Conference is set to take place from October 27 to 28, in Boston. A highlight of this conference will be a panel discussion involving Ryan Swanson, Ph.D., Lifecore’s director of process development. They will delve into the intricacies of effective manufacturing scale-up, a crucial aspect of moving from clinical development to commercial success.
Panel Participation
Ryan Swanson will lead the panel discussion titled "Achieving Effective Manufacturing Scaleup for Clinical and Commercial Success,” scheduled for 3:35 – 4:05 p.m. Eastern on October 28. Lifecore will also conduct meetings with existing and prospective customers to foster partnerships and collaboration, showcasing their booth number 601 to visitors.
CPHI Worldwide 2025 Participation
Conference Insights
Following the PODD, Lifecore will engage in CPHI Worldwide 2025 from October 28 to 30 in Frankfurt, Germany. This event is renowned for its expansive reach across the pharmaceutical industry, making it an ideal venue for Lifecore to establish robust business development and marketing connections.
Networking Opportunities
At CPHI, Lifecore will host meetings at their booth number 5.0B110, aiming to connect with both current and potential partners. This interaction will provide an opportunity for attendees to learn more about Lifecore’s innovative solutions and how they can support the pharmaceutical manufacturing landscape.
American Pharma Manufacturing & Outsourcing Summit 2025
Event Details
On November 17 and 18, Lifecore will also participate in the American Pharma Manufacturing & Outsourcing Summit in Boston. Like the previous events, Lifecore intends to make a significant impact through their marketing presence, engaging with industry stakeholders to explore new partnerships.
Future collaborations
While the exact booth number is yet to be determined, Lifecore encourages companies interested in collaboration to visit them during this crucial event. Their participation underscores their ongoing commitment to nurturing relationships within the pharmaceutical community.
Connecting with Lifecore Biomedical
If you wish to connect with Lifecore during these significant events or have inquiries regarding their participation, you can reach out to them through several channels. They are open to discussions and collaborations, which can be initiated via email at info@lifecore.com or by visiting their LinkedIn profile.
About Lifecore Biomedical
Lifecore Biomedical, Inc. (NASDAQ: LFCR) stands as a pioneering force in the contract development and manufacturing sector. With over 40 years of expertise, they specialize in the development, filling, and finishing of sterile injectable products. Their profound knowledge in creating injectable-grade hyaluronic acid positions them as a primary partner for biopharmaceutical and biotechnology companies aiming to introduce innovative therapies across diverse therapeutic areas.
Frequently Asked Questions
1. What conferences will Lifecore Biomedical participate in?
Lifecore will participate in the PODD Conference, CPHI Worldwide, and the American Pharma Manufacturing & Outsourcing Summit.
2. Who is representing Lifecore at the PODD Conference?
Ryan Swanson, Ph.D., Lifecore’s director of process development, will represent the company at the PODD Conference.
3. Where will the CPHI Worldwide Conference take place?
The CPHI Worldwide Conference will be held in Frankfurt, Germany.
4. How can companies connect with Lifecore at these events?
Companies can connect by visiting their booth or reaching out via email at info@lifecore.com.
5. What does Lifecore Biomedical specialize in?
Lifecore specializes in the contract development and manufacturing of sterile injectable pharmaceutical products, including hyaluronic acid.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.